Profile data is unavailable for this security.
About the company
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is engaged in dealing in pharmaceutical ingredient, pharmaceutical formulations, surgical products, herbal and nutraceutical products, veterinary supplements operating in domestic and export market. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceuticals, oncology, surgical and veterinary, among others. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The Company markets approximately 1,500 products and has more than 200 brands, around 35 countries.
- Revenue in INR (TTM)801.21m
- Net income in INR58.38m
- Incorporated2008
- Employees--
- LocationVaishali Pharma Ltd706-709, Aravalli Business Center R.C.Patel Road, Sodawala Lane, Borivili (West)MUMBAI 400092IndiaIND
- Phone+91 2 242171819
- Fax+91 2 228928833
- Websitehttps://www.vaishalipharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarey Drugs and Pharmaceuticals Ltd | 3.48bn | 42.19m | 1.43bn | 0.00 | 30.59 | -- | 24.95 | 0.4098 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.44bn | 89.00 | 23.32 | 9.09 | 23.48 | 2.48 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Krebs Biochemicals And Industries Ltd | 499.09m | -208.21m | 1.45bn | 210.00 | -- | -- | -- | 2.90 | -9.50 | -9.50 | 22.86 | -- | -- | -- | -- | 2,376,624.00 | -- | -18.88 | -- | -29.04 | 86.28 | 11.95 | -41.72 | -59.37 | -- | -3.78 | -- | -- | -12.68 | 9.07 | 44.55 | -- | 28.63 | -- |
| Mangalam Drugs and Organics Ltd | 3.57bn | -169.87m | 1.58bn | 523.00 | -- | -- | -- | 0.4419 | -10.74 | -10.74 | 225.21 | -- | -- | -- | -- | 6,834,930.00 | -- | 3.70 | -- | 6.50 | 26.38 | 29.07 | -4.75 | 2.87 | -- | -0.5682 | -- | -- | -17.47 | 5.91 | -93.54 | -42.32 | 11.78 | -- |
| Bal Pharma Ltd | 3.27bn | 35.19m | 1.62bn | -- | 47.35 | -- | 12.01 | 0.4968 | 2.17 | 2.17 | 209.85 | -- | -- | -- | -- | -- | -- | 0.1785 | -- | 0.4782 | 44.02 | 43.81 | 1.08 | 0.1865 | -- | 1.34 | -- | 132.38 | 8.18 | 7.54 | -54.17 | -1.56 | 31.09 | 0.00 |
| Vaishali Pharma Ltd | 801.21m | 58.38m | 1.76bn | -- | 30.63 | -- | 27.67 | 2.20 | 5.15 | 5.15 | 68.64 | -- | -- | -- | -- | -- | -- | 3.32 | -- | 8.64 | 17.72 | 15.06 | 7.29 | 3.71 | -- | 4.37 | -- | -- | -8.12 | 0.5072 | 64.12 | 52.62 | -4.18 | -- |
| Alpa Laboratories Limited | 1.15bn | 178.77m | 1.88bn | 318.00 | 10.46 | -- | 9.46 | 1.64 | 8.54 | 8.54 | 54.78 | -- | -- | -- | -- | 3,610,371.00 | -- | 5.39 | -- | 6.71 | 35.30 | 33.85 | 15.57 | 7.88 | -- | 109.23 | -- | -- | -17.20 | 8.14 | -10.71 | 34.99 | -10.58 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 1.05bn | 36.30m | 1.94bn | 632.00 | 53.40 | 3.54 | 29.13 | 1.86 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| SMS Lifesciences India Ltd | 2.96bn | 49.05m | 1.97bn | 567.00 | 40.21 | -- | 12.29 | 0.6668 | 16.23 | 16.23 | 978.01 | -- | -- | -- | -- | 5,218,087.00 | -- | 5.33 | -- | 8.84 | 29.00 | 26.60 | 0.6645 | 4.99 | -- | 0.8533 | -- | 2.32 | -9.77 | 7.73 | -54.65 | 12.01 | 69.24 | -- |
